Xenos Bio
- Biotech or pharma, therapeutic R&D
We are building a software application that enables the identification of binding motifs within functional domains in proteins through predicting protein-protein interactions. We do this by integrating a novel algorithm into a machine learning approach. Our technology is aimed at facilitating computational target lead generation for drug discovery purposes, which can accelerate the identification of drug candidates at a scale that was previously unattainable.
Our software, XenoProt, is initially being deployed in the construction of fully rational peptide library construction and has demonstrated a 2x enhancement in hit identification over gold standard libraries. We help biotech and biopharma realise up to 1,000x cost efficiency gains in highthroughput screening processes and we make this available to partners as a managed service.
We have also validated a series of novel lead candidates in the cardiometabolic space leveraging our unique physics-based function driven predictive model.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}